NCT03031483 2025-01-30
Clarithromycin + Lenalidomide Combination: a Full Oral Treatment for Patients With Relapsed/Refractory Extranodal Marginal Zone Lymphoma
International Extranodal Lymphoma Study Group (IELSG)
Phase 2 Completed
International Extranodal Lymphoma Study Group (IELSG)
M.D. Anderson Cancer Center
National Health Research Institutes, Taiwan
European Organisation for Research and Treatment of Cancer - EORTC